Reply to: New-onset aortitis manifesting as relapsing giant cell arteritis successfully managed with tocilizumab monotherapy. by Guarda et al
- PMID: 36995310
- DOI: 10.55563/clinexprheumatol/ht170k
Reply to: New-onset aortitis manifesting as relapsing giant cell arteritis successfully managed with tocilizumab monotherapy. by Guarda et al
Comment on
-
New-onset aortitis manifesting as relapsing giant cell arteritis successfully managed with tocilizumab monotherapy. A comment on: Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients. by Calderon-Goerc.Clin Exp Rheumatol. 2023 Apr;41(4):989-990. doi: 10.55563/clinexprheumatol/032qke. Epub 2023 Mar 20. Clin Exp Rheumatol. 2023. PMID: 36995327 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical